Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia
Diabetes Care - United States
doi 10.2337/dc06-1903
Full Text
Open PDFAbstract
Available in full text
Date
June 26, 2007
Authors
Publisher
American Diabetes Association